<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Antibodies to beta 2-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> I (beta 2-GPI) and antibodies to <z:chebi fb="0" ids="28494">cardiolipin</z:chebi> (aCL) were determined by enzyme immunoassay in 58 patients with verified SLE </plain></SENT>
<SENT sid="1" pm="."><plain>Elevated level of antibodies to beta 2-GPI was associated with development of <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (APS) and aCL hyperproduction </plain></SENT>
<SENT sid="2" pm="."><plain>It is evident that synthesis of antibodies to beta 2-GPI is an additional marker of APS in SLE </plain></SENT>
</text></document>